Eli Lilly weight loss drug approved in China
The Chinese drug regulator, the National Medical Products Administration (NMPA), has approved Eli Lilly’s (NYSE:LLY) weight ...
BioWorld4mon
China’s ‘growing enthusiasm’ for GLP-1s
After capturing the North American market with Wegovy (semaglutide) and Zepbound (tirzepatide), Novo Nordisk A/S and Eli ... Eyeing the success of GLP-1s are Chinese biopharmaceutical companies ...
National Institute for Health and Care Excellence1mon
Tirzepatide for managing overweight and obesity
Tirzepatide is recommended as an option for managing overweight ... Use a lower BMI threshold (usually reduced by 2.5 kg/m 2) for people from South Asian, Chinese, other Asian, Middle Eastern, Black ...
Hosted on MSN2mon
Hims & Hers closes up 10% as Lilly tirzepatide compounding dispute resolution delayed
In early October, the FDA said that the shortage of Lilly's Zepbound and Mounjaro, which both contain tirzepatide, was over. That prompted the Outsourcing Facilities Association to file its ...